Oncologist pleads guilty in misbranded drug case; AZ relies on old friend for API;

> Oncologist Isabella Martire bought $200,000 worth of cancer drugs not approved by the FDA for her Maryland patients from an English wholesaler and sought reimbursement from Medicare, Medicaid and other insurers. Story

> Bachem will continue to supply the peptide active ingredient Goserelin to AstraZeneca for 7 more years, as it has for the past two decades. Release

> MolMed of Italy will develop a production process for GlaxoSmithKline for a late-stage investigational gene therapy for bubble boy disease, ADA-SCID.  Article

> Umetrics, a provider of multivariate analysis software, aims to bring MVA to the batch and process manufacturing industries through partnerships with drugmakers Pfizer and Biogen Idec. Article

> Inspectors from the World Health Organization are helping three Nigerian pharma companies enhance standards and operations in a step toward WHO prequalification. Story

> German contract manufacturer Aenova will lease a manufacturing unit near Lyon, France, from U.K. drugmaker SkyePharma. Story

> Cadila Pharmaceuticals (Ethiopia) has earned the cGMP certificate and claims it's the first formulation manufacturing company in Africa to comply with WHO requirements. Story

> Akela of Austin, TX, will put all energies into its contract manufacturing business, PharmaForm, following termination of a drug development effort with Japanese partner, Teikoku Seiyaku. Release

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.